Newer obesity drugs linked to fewer alcohol-related hospitalizations for people with alcohol dependence

Use of newer GLP-1 receptor agonists (semaglutide oregon tirzepatide) for obesity oregon diabetes among radical with intoxicant usage upset was associated with a simplification successful alcohol-related infirmary admissions, according to a survey published online successful the open-access diary BMJ Open.